Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
McKesson
Medtronic

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for Astellas Pharma Inc. v. Eugia Pharma Specialities Ltd. (D. Del. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Astellas Pharma Inc. v. Eugia Pharma Specialities Ltd. (D. Del. 2018)

Docket   Start Trial Date Filed 2018-05-17
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm F. Connolly
Jury Demand None Referred To
Parties ASTELLAS PHARMA INC.; ASTELLAS PHARMA US, INC.; ASTELLAS US LLC; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA, INC.; EUGIA PHARMA SPECIALITIES LTD.; MEDIVATION LLC; MEDIVATION PROSTATE THERAPEUTICS LLC; REGENTS OF THE UNIVERSITY OF CALIFORNIA
Patents 7,709,517; 8,183,274; 9,126,941
Attorneys Benjamin J. Schladweiler; David A. Bilson; Derek James Fahnestock; Gary Ji; Jack B. Blumenfeld; John C. Phillips , Jr.; Joseph Schramm , III
Firms Greenberg Traurig, the Nemours Building; Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Astellas Pharma Inc. v. Eugia Pharma Specialities Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Astellas Pharma Inc. v. Eugia Pharma Specialities Ltd. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 4 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,709,517 B2 ;8,183,274 B2 ;9,126,941… 17 May 2018 1:18-cv-00757 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
AstraZeneca
McKinsey
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.